The CAPITA study of protein-conjugate pneumococcal vaccine and its implications for use in adults in developed countries

References

• Black SB, Shinefield HR, Fireman B, Hiatt R. Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use. J Infect Dis 1992; 165:Suppl 1 S139 - 43; http://dx.doi.org/10.1093/infdis/165-Supplement_1-S139; PMID: 1588149
   PubMedGoogle Scholar
• Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, et al, Northern California Kaiser Permanente Vaccine Study Center Group. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19:187 - 95; http://dx.doi.org/10.1097/00006454-200003000-00003; PMID: 10749457
   PubMed Web of Science ®Google Scholar
• Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, et al, Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201:32 - 41; http://dx.doi.org/10.1086/648593; PMID: 19947881
   PubMed Web of Science ®Google Scholar
• Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O’Brien KL, Moore MR, Serotype Replacement Study Group. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 2013; 10:e1001517; http://dx.doi.org/10.1371/journal.pmed.1001517; PMID: 24086113
   PubMed Web of Science ®Google Scholar
• Musher DM, Sampath R, Rodriguez-Barradas MC. The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?. Clin Infect Dis 2011; 52:633 - 40; http://dx.doi.org/10.1093/cid/ciq207; PMID: 21292668
   PubMed Web of Science ®Google Scholar
• Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2013; 1:CD000422; PMID: 23440780
   PubMed Web of Science ®Google Scholar
• Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008; CD000422; PMID: 18253977
   PubMedGoogle Scholar
• Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009; 180:48 - 58; http://dx.doi.org/10.1503/cmaj.080734; PMID: 19124790
   PubMed Web of Science ®Google Scholar
• Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, Hospital-Guardiola I. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study. Clin Infect Dis 2014; 58:909 - 17; http://dx.doi.org/10.1093/cid/ciu002; PMID: 24532544
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012; 61:816 - 9; PMID: 23051612
   PubMedGoogle Scholar
• Kumar D, Chen MH, Wong G, Cobos I, Welsh B, Siegal D, Humar A. A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients. Clin Infect Dis 2008; 47:885 - 92; http://dx.doi.org/10.1086/591537; PMID: 18715160
   PubMed Web of Science ®Google Scholar
• Ridda I, Musher DM. Is there a potential role for protein-conjugate pneumococcal vaccine in older adults?. Australas Med J 2012; 5:231 - 5; http://dx.doi.org/10.4066/AMJ.2012.1160; PMID: 22848316
   PubMedGoogle Scholar
• French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, Moore M, Antvelink D, Mulder D, Janoff EN, et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000; 355:2106 - 11; http://dx.doi.org/10.1016/S0140-6736(00)02377-1; PMID: 10902624
   PubMed Web of Science ®Google Scholar
• French N, Gordon SB, Mwalukomo T, White SA, Mwafulirwa G, Longwe H, Mwaiponya M, Zijlstra EE, Molyneux ME, Gilks CF. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med 2010; 362:812 - 22; http://dx.doi.org/10.1056/NEJMoa0903029; PMID: 20200385
   PubMed Web of Science ®Google Scholar
• Kumar D, Chen MH, Welsh B, Siegal D, Cobos I, Messner HA, Lipton J, Humar A. A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. Clin Infect Dis 2007; 45:1576 - 82; http://dx.doi.org/10.1086/523583; PMID: 18190318
   PubMed Web of Science ®Google Scholar
• Kumar D, Welsh B, Siegal D, Chen MH, Humar A. Immunogenicity of pneumococcal vaccine in renal transplant recipients--three year follow-up of a randomized trial. Am J Transplant 2007; 7:633 - 8; http://dx.doi.org/10.1111/j.1600-6143.2007.01668.x; PMID: 17217436
   PubMed Web of Science ®Google Scholar
• Karlsson J, Hogevik H, Anderssson K, Roshani L, Andreasson B, Wenneras C.. Pneumococcal vaccine responses in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance. Trials Vaccinol 2013; 2:31 - 8; http://dx.doi.org/10.1016/j.trivac.2013.09.001
   Google Scholar
• Musher DM, Thorner AL. Community-acquired pneumonia. N Engl J Med 2014; 372 In press
   Google Scholar
• Restrepo MI, Mortensen EM, Velez JA, Frei C, Anzueto A. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest 2008; 133:610 - 7; http://dx.doi.org/10.1378/chest.07-1456; PMID: 17989157
   PubMed Web of Science ®Google Scholar
• File TM Jr., Low DE, Eckburg PB, Talbot GH, Friedland HD, Lee J, Llorens L, Critchley I, Thye D. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. Clin Infect Dis 2010; 51:1395 - 405; http://dx.doi.org/10.1086/657313; PMID: 21067350
   PubMed Web of Science ®Google Scholar
• Musher DM, Roig IL, Cazares G, Stager CE, Logan N, Safar H. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect 2013; 67:11 - 8; http://dx.doi.org/10.1016/j.jinf.2013.03.003; PMID: 23523447
   PubMed Web of Science ®Google Scholar